Chaping Cheng

829 total citations
11 papers, 365 citations indexed

About

Chaping Cheng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chaping Cheng has authored 11 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Chaping Cheng's work include Cancer Cells and Metastasis (4 papers), Prostate Cancer Treatment and Research (3 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). Chaping Cheng is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Prostate Cancer Treatment and Research (3 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). Chaping Cheng collaborates with scholars based in China, Sweden and France. Chaping Cheng's co-authors include Wei‐Qiang Gao, Helen He Zhu, Zhongzhong Ji, Huifang Zhao, Xue Wang, Yanjing Guo, Li Li, Yaru Sheng, Xiaoxia Li and Dawei Xu and has published in prestigious journals such as Nature Communications, Cancer Research and Clinical Cancer Research.

In The Last Decade

Chaping Cheng

10 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chaping Cheng China 9 222 112 98 91 51 11 365
Andrea C. Chaikovsky United States 6 290 1.3× 169 1.5× 73 0.7× 98 1.1× 33 0.6× 7 437
Suzanne R.L. Young United States 13 301 1.4× 137 1.2× 93 0.9× 66 0.7× 37 0.7× 20 455
Cera Nieto United States 9 198 0.9× 136 1.2× 89 0.9× 101 1.1× 69 1.4× 10 349
Ayse Ceren Mutgan Germany 7 152 0.7× 131 1.2× 110 1.1× 94 1.0× 70 1.4× 12 348
Simona Nuzzo Italy 7 222 1.0× 214 1.9× 46 0.5× 84 0.9× 65 1.3× 10 388
Robyn T. Sussman United States 11 331 1.5× 160 1.4× 61 0.6× 106 1.2× 35 0.7× 24 468
Renya Zhang China 11 162 0.7× 92 0.8× 84 0.9× 69 0.8× 25 0.5× 21 290
Natalie L. Lister Australia 9 137 0.6× 148 1.3× 81 0.8× 45 0.5× 111 2.2× 12 364
Alessia Centonze Belgium 5 217 1.0× 229 2.0× 44 0.4× 75 0.8× 35 0.7× 7 338
Lei Bian China 11 264 1.2× 137 1.2× 32 0.3× 108 1.2× 46 0.9× 18 398

Countries citing papers authored by Chaping Cheng

Since Specialization
Citations

This map shows the geographic impact of Chaping Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaping Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaping Cheng more than expected).

Fields of papers citing papers by Chaping Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaping Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaping Cheng. The network helps show where Chaping Cheng may publish in the future.

Co-authorship network of co-authors of Chaping Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Chaping Cheng. A scholar is included among the top collaborators of Chaping Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaping Cheng. Chaping Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Chen, Xinyu, Jinming Wang, Kaiyuan Liu, et al.. (2024). Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer. Cell Death and Differentiation. 31(6). 779–791. 28 indexed citations
3.
Sun, Di, Huanhuan Guo, Chaping Cheng, et al.. (2023). Abstract 465: The preclinical characterization of TST003, a first-in-class mAb targeting gremlin-1 overexpressed by cancer-associated fibroblasts and tumor cells. Cancer Research. 83(7_Supplement). 465–465. 3 indexed citations
4.
Jing, Na, Deng Wang, Penghui Xu, et al.. (2021). A novel mouse model for liver metastasis of prostate cancer reveals dynamic tumour‐immune cell communication. Cell Proliferation. 54(7). e13056–e13056. 10 indexed citations
5.
Wang, Xue, Haibo Xu, Chaping Cheng, et al.. (2020). Identification of a Zeb1 expressing basal stem cell subpopulation in the prostate. Nature Communications. 11(1). 706–706. 47 indexed citations
6.
Ji, Zhongzhong, Yaru Sheng, Juju Miao, et al.. (2019). The histone methyltransferase Setd2 is indispensable for V(D)J recombination. Nature Communications. 10(1). 3353–3353. 36 indexed citations
7.
Sheng, Yaru, Zhongzhong Ji, Huifang Zhao, et al.. (2019). Downregulation of the histone methyltransferase SETD2 promotes imatinib resistance in chronic myeloid leukaemia cells. Cell Proliferation. 52(4). e12611–e12611. 11 indexed citations
8.
Cheng, Chaping, Zhongzhong Ji, Yaru Sheng, et al.. (2018). Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signaling. Theranostics. 8(17). 4633–4648. 33 indexed citations
9.
Wang, Xue, Baijun Dong, Kai Zhang, et al.. (2018). E-cadherin bridges cell polarity and spindle orientation to ensure prostate epithelial integrity and prevent carcinogenesis in vivo. PLoS Genetics. 14(8). e1007609–e1007609. 48 indexed citations
10.
Zhang, Kai, Yanjing Guo, Xue Wang, et al.. (2017). WNT/β-Catenin Directs Self-Renewal Symmetric Cell Division of hTERThigh Prostate Cancer Stem Cells. Cancer Research. 77(9). 2534–2547. 112 indexed citations
11.
Guo, Yanjing, Kai Zhang, Chaping Cheng, et al.. (2017). Numb−/low Enriches a Castration-Resistant Prostate Cancer Cell Subpopulation Associated with Enhanced Notch and Hedgehog Signaling. Clinical Cancer Research. 23(21). 6744–6756. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026